Eli Lilly and (LLY) | Stock Overview & Key Data

Eli Lilly and Company | Healthcare

$808.61

0.18%

| Eli Lilly and Stock Comparison:

Eli Lilly and vs Johnson & Johnson Eli Lilly and vs AbbVie Eli Lilly and vs Merck & Co Eli Lilly and vs Amgen Eli Lilly and vs Gilead Sciences Eli Lilly and vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Eli Lilly and Performance Comparison

Loading chart data...

Eli Lilly and

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $805.03 High: $820.72

on June 11, 2025

52 Week Range

Low: $677.09 High: $972.53

on April 7, 2025

on August 22, 2024

All-Time High: $972.53 on August 19, 2024

Key Statistics

Market Cap i $725.0B

EPS i 12.30

P/E Ratio (TTM) i 65.66

Forward P/E i 35.64

P/B Ratio i 48.55

PEG Ratio i 35.64

Div. Yield i 0.67%

ROE i 77.28%

Beta i 0.394

Debt to Equity i 243.61

Financial Highlights

Profitability

Gross Margin i 82.53%

Operating Margin i 42.49%

Profit Margin i 22.67%

Returns and Earnings

Return on Assets (TTM) i 16.45%

Return on Equity (TTM) i 77.28%

EBITDA i $22.1B

Net Income (TTM) i $11.1B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $6.00

Estimated Dividend Yield i 0.74%

5 Year Average Dividend Yield i 1.11%

Last 12-Month Dividend Yield i 0.67%

Last 12-Month Dividend i $5.40

% of Earnings Paid as Dividends i 43.94%

Dividend Date i June 10, 2025

Ex-Dividend Date i May 16, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Eli Lilly and LLY	725.05B Mega-cap	5.59%	7.02%	-1.87%	1.58%	3.93%	-7.92%	178.07%	405.76%
Johnson & Johnson JNJ	376.43B Mega-cap	1.32%	0.72%	-6.40%	5.87%	7.80%	6.67%	-8.39%	7.94%
AbbVie ABBV	338.27B Mega-cap	2.21%	0.74%	-10.35%	9.81%	6.71%	13.58%	38.48%	98.00%
Merck & Co MRK	204.27B Mega-cap	2.62%	-0.14%	-15.21%	-19.48%	-19.01%	-37.97%	-5.08%	8.06%
Amgen AMGN	156.11B Large-cap	1.70%	6.24%	-8.46%	6.76%	12.58%	-2.26%	24.34%	22.27%
Gilead Sciences GILD	136.94B Large-cap	0.27%	5.29%	-4.47%	18.33%	18.97%	68.04%	86.79%	41.13%

Ownership & Short Interest

Insider Ownership i 0.16%

Institutional Ownership i 84.08%

Shares Short i 7M

Short Ratio i 1.46

Short % of Shares Outstanding i 0.92%

Average 10-Day Volume i 3M

Average 90-Day Volume i 4M

Eli Lilly and Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Eli Lilly and would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is LLY's 52-week high and low?

In the last 52 weeks, Eli Lilly and reached a high of $972.53 (on August 22, 2024) and a low of $677.09 (on April 7, 2025).

What is the market cap and P/E ratio for LLY?

Curious about Eli Lilly and's size and valuation? Its market capitalization stands at 725.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 65.66, and the forward P/E (looking ahead) is 35.64.

Does LLY pay dividends? If so, what's the yield?

Yes, Eli Lilly and is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.67%, and the company is expected to pay out $6.00 per share over the coming year.

Who are Eli Lilly and's main competitors or similar companies to consider before investing?

When looking at Eli Lilly and, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Johnson & Johnson JNJ	376.43B	Healthcare	Drug Manufacturers - General	6.67%	-8.39%
AbbVie ABBV	338.27B	Healthcare	Drug Manufacturers - General	13.58%	38.48%
Merck & Co MRK	204.27B	Healthcare	Drug Manufacturers - General	-37.97%	-5.08%
Amgen AMGN	156.11B	Healthcare	Drug Manufacturers - General	-2.26%	24.34%
Gilead Sciences GILD	136.94B	Healthcare	Drug Manufacturers - General	68.04%	86.79%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Eli Lilly and Company? (e.g., ROE, Debt/Equity)

To get a sense of Eli Lilly and's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 77.28%, the Debt to Equity ratio from the most recent quarter is 243.61, and its Gross Profit Margin stands at 82.53%.

What is the recent revenue and earnings growth for LLY?

Looking at Eli Lilly and's growth, its revenue over the trailing twelve months (TTM) was $49B. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.20%, and quarterly earnings saw a YoY growth of 23.00%.

How much of LLY stock is held by insiders and institutions?

Wondering who owns Eli Lilly and stock? Company insiders (like executives and directors) hold about 0.16% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 84.08%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.